Dr. Rebeca Mayol-Sharp, M.D.
What this data tells you about Dr. Mayol-Sharp
Dr. Rebeca Mayol-Sharp is an internal medicine in Euless, TX, with 20 years in practice. Based on federal Medicare data, Dr. Mayol-Sharp performed 2,492 Medicare services across 1,928 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mayol-Sharp received a total of $9,634 from 63 pharmaceutical and/or device companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mayol-Sharp is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) | 586 | $55 | $171 |
| Annual wellness visit, follow-up | 210 | $128 | $268 |
| Comprehensive metabolic blood panel | 187 | $10 | $25 |
| Lipid panel (cholesterol and triglycerides) | 178 | $13 | $35 |
| Thyroid stimulating hormone (TSH) test | 147 | $16 | $40 |
| Annual depression screening | 145 | $18 | $28 |
| Dexamethasone injection (steroid) | 144 | $0 | $5 |
| Complete blood count (CBC) with differential | 133 | $8 | $20 |
| Hemoglobin A1c test (diabetes monitoring) | 116 | $10 | $84 |
| Office visit, established patient (30-39 min) | 94 | $83 | $230 |
| Vitamin D level test | 90 | $29 | $53 |
| Flu vaccine administration | 54 | $17 | $17 |
| Flu vaccine, quadrivalent | 51 | $76 | $215 |
| Free thyroxine (T4) test | 45 | $9 | $35 |
| Drug injection, under skin or into muscle | 45 | $9 | $36 |
| Injection, methylprednisolone acetate, 80 mg | 34 | $8 | $23 |
| Transitional care management services for problem of at least moderate complexity | 26 | $151 | $315 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 23 | $159 | $187 |
| Urine microalbumin (protein) analysis | 22 | $6 | $25 |
| Manual urinalysis test with examination using microscope, non-automated | 21 | $4 | $22 |
| Magnesium level test | 21 | $7 | $40 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 20 | $6 | $59 |
| Basic metabolic blood panel | 19 | $8 | $20 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 16 | $140 | $339 |
| Automated urinalysis | 15 | $2 | $20 |
| Electrocardiogram (EKG), 12-lead | 14 | $8 | $61 |
| Thyroid hormone, t3 measurement, free | 13 | $17 | $105 |
| Prostate cancer screening; prostate specific antigen test (psa) | 12 | $19 | $40 |
| Sed rate test (inflammation marker) | 11 | $3 | $20 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for internal medicine in TX.
Geographic Context
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mayol-Sharp is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), and high industry engagement (low-engagement, top 9%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mayol-Sharp experienced with office visit, established patient (20-29 min)?
Does Dr. Mayol-Sharp receive payments from pharmaceutical companies?
How do Dr. Mayol-Sharp's costs compare to other internal medicines in Euless?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology